Correspondence 0001193125-23-130506 from CONTRAFECT Corp (CFRXQ) (CIK 0001478069)
CONTRAFECT Corp (CFRXQ) (CIK 0001478069)
Date: May 1, 2023 · CIK: 0001478069 · Accession: 0001193125-23-130506
AI Filing Summary & Sentiment
File numbers found in text: 333-269673
Show Raw Text
CORRESP 1 filename1.htm CORRESP CONTRAFECT CORPORATION 28 Wells Avenue, Third Floor Yonkers, New York 10701 May 1, 2023 VIA EDGAR TRANSMISSION Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Jason Drory Re: CONTRAFECT CORPORATION Registration Statement on Form S-3 (Registration No. 333-269673) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (Registration No. 333- 269673) (as amended, the “Registration Statement”) of ContraFect Corporation (the “Company”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Eastern Time, on May 3, 2023, or at such later time as the Company or its counsel may orally request via telephone call to the staff. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Peter Handrinos at (617) 948-6060 or Wesley Holmes at (617) 948-6027. If you have any questions regarding the foregoing, please do not hesitate to contact Peter Handrinos at (617) 948-6060 or Wesley Holmes at (617) 948-6027, of Latham & Watkins LLP. Thank you in advance for your consideration. Very truly yours, CONTRAFECT CORPORATION By: /s/ Michael Messinger Name: Michael Messinger Title: Chief Financial Officer cc: Peter N. Handrinos, Latham & Watkins LLP Wesley C. Holmes, Latham & Watkins LLP